Biotechnology News

September 11, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--NEW DATA FROM ENDORSE SHOW POSITIVE RESULTS CONTINUED OVER FIVE YEARS WITH TECFIDERA® (DIMETHYL FUMARATE)
IN A WIDE RANGE OF MULTIPLE SCLEROSIS PATIENTS

September 11, 2014

WILMSLOW, U.K.--(BUSINESS WIRE)--Waters Corporation (NYSE: WAT) today celebrated the official opening of its new, custom-built mass spectrometry headquarters in Wilmslow, UK, confirming the company's commitment to innovation and the expanded...

September 11, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today positive interim results from the second year of the extension study of Lemtrada™ (alemtuzumab) for multiple sclerosis. In this analysis,...

September 10, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) announced today that Baxalta Incorporated will be the name of the new, publicly traded biopharmaceutical company that is expected to launch in mid-2015. Upon completion of the...

September 10, 2014

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (NASDAQ:FCSC), an autologous cell therapy company focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs, today...

September 10, 2014

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Announces First Patient Enrolled in Lucitanib Phase 2 Study in FGF aberrant advanced breast cancer

September 10, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida names James Barry to Board of Directors. Barry is currently Ex. VP and COO of InspireMD, global medical device company. Formerly with Arsenal Medical and Boston Scientific Corporation.

September 10, 2014

HOUSTON--(BUSINESS WIRE)--TOPS Comprehensive Breast Center, Houston, TX, is proud to have been a part of a recent study conducted by Stephen L. Rose, M.D., Medical Director of TOPS Comprehensive Breast Center, and colleagues (Andra L. Tidwell,...

September 10, 2014

WASHINGTON--(BUSINESS WIRE)--Polsinelli PC will sponsor two sessions, one on the importance of protecting patent rights and the second on utilizing biotechnology to better human and animal health at the 2014 BIO LBS

September 10, 2014

WASHINGTON--(BUSINESS WIRE)--ACRO announces that Senator Tom Carper (D-DE) and Congressman Fred Upton (R-MI) have been named its 2014 Legislators of the Year, to coincide with ACRO’s first-ever Innovation Month this September.

September 10, 2014

APPLETON, Wis.--(BUSINESS WIRE)--On Sunday, September 14th, Deb Nett of Appleton, Wisconsin will participate in the Courage Over Cancer 5k, and do what was once considered impossible - walk without a wheelchair thanks to BalanceWear.

September 10, 2014

NEW YORK--(BUSINESS WIRE)--Agilis Biotherapeutics, LLC, a synthetic biology-based company focused on developing DNA-based therapeutics for rare genetic diseases, announced today the appointment of Dr. Mark Pykett as President and CEO. Dr. Pykett...

September 10, 2014

LITTLE ROCK, Ark.--(BUSINESS WIRE)--Cantrell Drug Company enters exclusive agreement with Aseptic Technologies to become first compounding outsourcing facility to use closed vial system for filling of injectable drugs for hospitals.

September 10, 2014

SAN DIEGO--(BUSINESS WIRE)--SynteractHCR is attending a number of events and delivering presentations throughout the fall to educate and share their insights with colleagues in the biopharma and life sciences industries.

September 10, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that AbbVie,...

September 10, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Viamet Pharmaceuticals today reported that positive preclinical studies for VT-1161, the Company’s lead novel, oral antifungal compound were presented at the 54th Interscience Conference on...

September 10, 2014

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Boston Biomedical Associates, a product development consultancy and full-service contract research organization announces three key appointments to the BBA senior management team.

September 10, 2014

HEIDELBERG, Germany--(BUSINESS WIRE)--Novaliq GmbH, a drug delivery company focusing on the topical application of ophthalmic technologies for poorly soluble drugs, today announced that its observational study NT-001, which placed NovaTears® OTC...

September 10, 2014

WASHINGTON--(BUSINESS WIRE)--America’s biopharmaceutical research companies are currently developing 44 medicines and vaccines for HIV/AIDS treatment and prevention, according to the latest Medicines in Development report by the Pharmaceutical...

September 10, 2014

BASKING RIDGE, N.J.--(BUSINESS WIRE)--Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), today announced key hires as the company continues to build its executive management capabilities. The company has identified...

September 10, 2014

BOTHELL, Wash. & COPENHAGEN, Denmark--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) and Genmab A/S (OMX: GEN) today announced that the companies have entered into an additional antibody-drug conjugate (ADC) collaboration. Under the...

September 10, 2014

MUNICH--(BUSINESS WIRE)--The Diaverum Competence in Practice (CiP) programme, a pillar of the broader Diaverum nurse education programme, has been re-accredited for three years by the European Dialysis & Transplant Nurses Association/European...

September 10, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of the Solaris™ quantitative optical molecular imaging system. This preclinical solution...

September 10, 2014

MIRAMAR, Fla. & SHENZHEN, China--(BUSINESS WIRE)--Altor BioScience Corporation (Altor), a U.S.-based developer of novel cancer immunotherapies, and Shenzhen Beike Biotechnology Co., Ltd. (Beike), a leading Chinese cell-based therapy company,...

September 10, 2014

WASHINGTON--(BUSINESS WIRE)--AUTM releases highlights of Licensing Activity Survey, cites growth and need for sustained federal research funding.

September 10, 2014

BURLINGTON, Vt.--(BUSINESS WIRE)--Mach7 Technologies adds Radiology and Imaging Specialists to its expanding client roster

September 10, 2014

NEW YORK & DUBLIN--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, and ICON plc, (NASDAQ:ICLR) a global provider of outsourced development services to the...

September 10, 2014

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI adds University of Minnesota’s Masonic Cancer Center as the 7th clinical site in the U.S. to join its Phase III head and neck cancer clinical trial.

September 10, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq:XNPT) announced today that it will present data on XP23829, an investigational prodrug of monomethyl fumarate (MMF), at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston. Data being...

September 10, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Liquidia Technologies today announced the formation of a new pharmaceutical company, Lq3 Pharmaceuticals, dedicated to advancing novel therapies for oral health conditions. Leveraging the PRINT® (...

September 10, 2014

ALISO VIEJO, Calif.--(BUSINESS WIRE)--A new blood test reliably predicts whether a person is likely to develop Alzheimer’s Disease (AD) up to 10 years before the disease is diagnosed, according to a multi-site study recently published in the...

September 10, 2014

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the U.S. Food and...

September 10, 2014

REGENSBURG, Germany--(BUSINESS WIRE)--Transcatheter Technologies will report one-year follow-up results for study of its ‘truly repositionable’ Trinity TAVI system at ‘TCT 2014’ in Washington, DC

September 10, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme announces the launch of Expression of Hope III, a global program of inspiration and awareness featuring works of art by the community of people affected by lysosomal storage disorders (LSD).

September 10, 2014

RAMSEY, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (OTCQB:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious...

September 10, 2014

SAN MATEO, Calif.--(BUSINESS WIRE)--Afferent Pharmaceuticals, a leader in the development of small molecule compounds targeting P2X3 for respiratory, urologic and pain disorders, announced today that Kathleen Sereda Glaub has been named Chief...

September 10, 2014

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ:CERS) announced today that it has submitted a clinical protocol to the U.S. Food and Drug Administration (FDA) to make the INTERCEPT Blood System for platelets available under an...

September 10, 2014

TAMPA, Fla.--(BUSINESS WIRE)--Oragenics Appoints Key Hires to Drive Lantibiotic Platform Growth and Expansion

September 10, 2014

STOCKHOLM--(BUSINESS WIRE)--AstraZeneca: (STO:AZN)(LSE:AZN) E-health company Trialbee signs professional service agreement with AstraZeneca for e-recruitment. Trialbee enables AstraZeneca to recruit patients into specific clinical trials faster...

September 10, 2014

FREMONT, Calif.--(BUSINESS WIRE)--Cordis Corporation announced today the launch of its INCRAFT® AAA Stent Graft System (INCRAFT® System), an ultra-low profile device for use during endovascular aneurysm repair (EVAR) for patients suffering from...

September 10, 2014

BERKELEY, Calif.--(BUSINESS WIRE)--Zephyrus Biosciences, Inc., a life science research tools company, announced today that it has secured $1.86 million in funding to develop and commercialize its single cell Western blotting (scWestern) system to...

September 10, 2014

NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced...

September 10, 2014

ARDSLEY, N.Y.--(BUSINESS WIRE)--Results from a large-scale retrospective claims database study assessing real-world use of AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg will be presented by Acorda Therapeutics, Inc. (Nasdaq:ACOR) and...

September 10, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--NEW INTERNATIONAL SURVEY FINDS MS PATIENTS AND NEUROLOGISTS VIEW COMMUNICATION POSITIVELY, YET STRUGGLE TO DISCUSS KEY MS SYMPTOMS